Adsorptive Loss: Where the Peptide Goes When It Is Not in the Tube

A measured quantity of peptide is dissolved in a measured volume of solvent, and the resulting solution is weaker than the arithmetic says. Nothing degraded and nothing was spilled. Some fraction of the material is stuck to the inside of the container, and at low concentrations that fraction can be most of it.

Why peptides stick

Adsorption is the accumulation of molecules at a surface, and peptides are unusually good at it because they present several kinds of interaction at once. Charged side chains bind ionically to charged surfaces. Hydrophobic residues bury themselves against hydrophobic ones. Hydrogen bonding contributes throughout.

Which mechanism dominates depends on the surface. Borosilicate glass carries a negatively charged silanol surface at neutral pH, so basic peptides — those with a high proportion of arginine and lysine — bind to it strongly. Polypropylene is hydrophobic, so hydrophobic sequences bind preferentially there. A peptide that behaves well in plastic can behave badly in glass, and the reverse, which is why there is no universally correct container.

The concentration dependence is the whole story

A surface has a finite number of binding sites, so the quantity adsorbed is roughly fixed for a given container and peptide. The proportion lost therefore depends entirely on how much was there to begin with.

At a milligram per millilitre, a microgram lost to the walls is a rounding error. At a microgram per millilitre, the same absolute loss is a large fraction of the sample. This is counter-intuitive in practice because the problem appears at exactly the point where the analyst is least likely to suspect it: the dilute working standard, not the concentrated stock.

Serial dilution compounds it. Each vessel in the chain takes its share, and the loss at each step is proportionally larger than the one before, so the final solution can be substantially weaker than its nominal concentration while every intermediate looked fine.

Where it happens that nobody counts

• Pipette tips. Brief contact, large surface area relative to the volume held, and a fresh unsaturated surface every time. Tips are changed constantly, which means the loss is repeated rather than exhausted, and it compounds the volumetric error covered in pipetting accuracy and volumetric error.
• Autosampler vials and inserts. A dilute sample sitting for hours before injection has time to equilibrate with the walls — one of the several things happening in the gap between the vial and the autosampler.
• Filter membranes. Large surface area by design, and it binds.
• Transfer vessels. Every intermediate container in a preparation is another surface.

The selective version, which is worse

Uniform loss changes a concentration. Selective loss changes a composition, and that is a different kind of problem.

If the target peptide adsorbs more strongly than one of its impurities, the impurity is enriched in what remains in solution, and a purity measured on that solution is lower than the material’s true purity. If the reverse holds, the measured purity is flattering. Aggregates produced by the agitation described in vortexing, sonication and shear behave the same way, for the same reason. Neither shows up as an anomaly on the chromatogram — the peaks are simply in the wrong ratio, and the trace looks entirely normal, which is why this failure mode is invisible without a recovery check.

What actually reduces it

• Low-binding consumables. Tubes and tips sold as low-bind or protein-lo-bind carry a surface treatment that reduces both ionic and hydrophobic interaction. They are not zero-binding, and they are not a substitute for the measures below at very low concentrations.
• Organic solvent in the diluent. Even five to ten percent acetonitrile substantially reduces hydrophobic adsorption, provided the solvent is compatible with the downstream method.
• Moving the pH away from the peptide’s isoelectric point changes the net charge and therefore the ionic component of binding, with the solubility consequences described in isoelectric point and solubility.
• A carrier or surfactant. An unrelated protein or a small quantity of a non-ionic surfactant saturates the binding sites so the analyte stays in solution. This is effective and it contaminates the sample, so it belongs in bioassay work far more than in analytical work.
• Pre-rinsing the container with a portion of the same solution, then discarding it, saturates the surface before the real sample goes in. The same logic as discarding the first portion of a filtrate.
• Fewer transfers. The most reliable mitigation is structural: prepare in the vessel the measurement will be made from, and avoid intermediate containers entirely.

Detecting it rather than assuming it

Adsorptive loss is easy to confirm and rarely checked. Prepare the solution, measure it, transfer it to a second identical container, leave it for the same interval, and measure again. A drop between the two is adsorption, since nothing else changed.

A concentration determination by absorbance, as described in concentration by A280, compared against the nominal value from the weighing, gives the same answer in one step — provided the sequence contains a residue that absorbs, which not all do.

Why this is not a certificate problem

Every figure on a certificate was obtained from a solution somebody prepared, and the same effect applied there. A well-run laboratory manages it with saturation and minimal transfers, and the residual error is folded into the uncertainty discussed in measurement uncertainty.

What it does explain is a specific and common experience downstream: material that arrives with a credible certificate and appears weaker than expected in dilute use. Before concluding the vial was underfilled or the peptide degraded, the cheaper hypothesis is that some of it never left the tube it was diluted in.